A status update of modified oligonucleotides for chemotherapeutics applications (Q37929073)

25 August 2017

1 reference

title

A status update of modified oligonucleotides for chemotherapeutics applications (English)

1 reference

25 August 2017

1 reference

Yogesh S Sanghvi

1 reference

25 August 2017

publication date

1 September 2011

1 reference

Current protocols in nucleic acid chemistry / editorial board, Serge L. Beaucage ... [et al.]

25 August 2017

published in

1 reference

25 August 2017

volume

Chapter 4

1 reference

25 August 2017

page(s)

Unit 4.1.1-22

1 reference

Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

Chemical modification of siRNAs for in vivo use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

A case study: oligonucleotide purification from gram to hundred gram scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

Trichloroacetaldehyde modified oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

21 January 2018

Aptamers as therapeutics

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

Silencing of microRNA families by seed-targeting tiny LNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

Unlocked nucleic acid--an RNA modification with broad potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

Process research on the preparation of DMT protected 2'-O-methoxyethylguanosine for oligonucleotide synthesis in therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

Therapeutic applications of DNA and RNA aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

Clinical status of duplex RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F0471142700.NC0401S46

10.1002/0471142700.NC0401S46

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference